Vimarsana
Biggest News Aggregation in the World

Page 5 - Michael Downes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Downes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Downes Today - Breaking & Trending Today

High-fat diet changes gut bacteria, bile acids, and increases colorectal cancer risk - Vimarsana News

High-fat diet changes gut bacteria, bile acids, and increases colorectal cancer risk

The prevalence of colorectal cancer in people under the age of 50 has risen in recent decades. One suspected reason: the increasing rate of obesity and high-fat diets.

Does this explain epidemic of colorectal cancers in young Americans? - Vimarsana News

Does this explain epidemic of colorectal cancers in young Americans?

High-fat diets could be driving America's colorectal cancer epidemic in young people, a study suggests. The cancer is expected to double in young people by 2030.

Keith A. Goldan Sells 577 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stock - Vimarsana News

Keith A. Goldan Sells 577 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stock

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) CFO Keith A. Goldan sold 577 shares of the business’s stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $22.31, for a total value of $12,872.87. Following the transaction, the chief financial officer now owns 2,628 shares of the company’s […]

Source: wkrb13.com
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Holdings Lessened by HealthCor Management L.P. - Vimarsana News

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Holdings Lessened by HealthCor Management L.P.

HealthCor Management L.P. lowered its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) by 91.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 70,000 shares of the company’s stock after selling 789,240 shares during the period. Syndax Pharmaceuticals makes up about […]

Eversept Partners LP Acquires 409,279 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Vimarsana News

Eversept Partners LP Acquires 409,279 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

Eversept Partners LP grew its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) by 33.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,620,713 shares of the company’s stock after purchasing an additional 409,279 shares during the quarter. Syndax Pharmaceuticals comprises 3.8% of […]